- Details
- Description
-
Packaging Size14t/bottle
-
Strength30mg
-
CompositonTenapanor
-
TreatmentReduce serum phosphorus in adults with chronic kidney disease (CKD)
-
FormTablet
-
BrandLuciTena
-
Quantity Unit30mg*14t/Box
-
ManufacturerLucius Pharmaceuticals (Lao) Co.,Ltd
About Tenapanor
Tenapanor is an inhibitor of the sodium-proton exchanger NHE3. This antiporter protein is found in the kidney and intestines, and normally acts to regulate the levels of sodium absorbed and secreted by the body. When administered orally, tenapanor selectively inhibits sodium uptake in the intestines, limiting the amount absorbed from food, and thereby reduces levels of sodium in the body.This may make it useful in the treatment of chronic kidney disease and hypertension, both of which are exacerbated by excess sodium in the diet.
About LuciTena
Indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in those who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy
30 mg PO BID immediately before breakfast and dinner
